Deoxycholic acid is one of the better-studied injectable compounds in aesthetic medicine. The evidence covers both efficacy and safety, with consistent findings across different study designs and patient populations.
A systematic review and meta-analysis published in the Expert Review of Clinical Pharmacology (Cunha et al., 2021), incorporating data from five randomised controlled trials and 1,838 participants, found that deoxycholic acid produced statistically significant improvements across all efficacy measures compared to placebo. Withdrawal rates due to adverse events were low at the standard dose, and the authors reported no clinically significant changes in liver or kidney function.
A separate systematic review published in Dermatologic Surgery (Pham et al., 2020), which analysed 28 published studies on the adverse event profile of deoxycholic acid, concluded that the large majority of patients experienced only mild, localised side effects that resolved on their own. Severe long-term adverse events were reported as rare across the evaluated literature.
Together, this research supports fat dissolving as a safe treatment for localised fat reduction when correctly administered — not a claim of zero risk, but a treatment with a well-characterised and manageable safety profile.
